HUM vs CLOV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: May 27, 2026

HUM

60.8
AI Score
VS
HUM Wins

CLOV

55.4
AI Score

Investment Advisor Scores

HUM

61score
Recommendation
BUY

CLOV

55score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric HUM CLOV Winner
Forward P/E 33.7838 81.9672 HUM
PEG Ratio 1.7444 0 Tie
Revenue Growth 23.5% 62.0% CLOV
Earnings Growth -4.6% 0.0% CLOV
Tradestie Score 60.8/100 55.4/100 HUM
Profit Margin 0.8% -2.6% HUM
Beta 1.00 1.00 Tie
AI Recommendation BUY HOLD HUM

Frequently Asked Questions

Based on our detailed analysis, HUM is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.